Sunshine Biopharma Inc (SBFM)

[Jean Naymar]

After a company issues an IPO, insiders and underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates on the company for a set period of time as a result of SEC regulations. This period of time is often referred to as a quiet period. Following the end of a company's quiet period, brokerages that served as underwriters often initiate research coverage on the company.